John F Thero's Net Worth
$60.9 Million
Who is John F Thero?
John F Thero has an estimated net worth of $60.9 Million. This is based on reported shares across multiple companies, which include AMARIN CORP PLC\UK, ACUSPHERE INC, VIACELL INC, Cyteir Therapeutics, Inc., , and CHIASMA, INC.
SEC CIK
John F Thero's CIK is 0001199637
Past Insider Trading and Trends
2020 was John F Thero's most active year for acquiring shares with 34 total transactions. John F Thero's most active month to acquire stocks was the month of January. 2020 was John F Thero's most active year for disposing of shares, totalling 43 transactions. John F Thero's most active month to dispose stocks was the month of December. 2018 saw John F Thero paying a total of $2,670,674.85 for 3,264,528 shares, this is the most they've acquired in one year. In 2019 John F Thero cashed out on 2,337,498 shares for a total of $29,860,446.73, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AMARIN CORP PLC\UK (AMRN) Snapshot price: $0.6094
President and CEOJohn F Thero owns 3,252,752 units of Ordinary Shares which is worth $1,982,227.07 and 304,400 units of Ordinary Shares (1) which is worth $185,501.36.acquired a total of 8,663,450 shares in AMARIN CORP PLC\UK at a cost of $4,629,431.49, John also disposed a total of 5,374,098 shares of AMARIN CORP PLC\UK equalling to $63,465,981.96.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.50% | 16.34K |
$4.14 | -$43,900.56 | 3.25M |
Jul 30
| |||
Form 4
| +0.51% | 16.34K |
$4.48 | -$47,505.92 | 3.24M |
Jun 30
| |||
Form 4
| +0.51% | 16.34K |
$4.54 | -$48,142.16 | 3.22M |
May 28
| |||
Form 4
| +0.51% | 16.34K |
$5.24 | -$55,564.96 | 3.2M |
Apr 30
| |||
Form 4
| +0.52% | 16.34K |
$6.37 | -$67,547.48 | 3.19M |
Mar 31
| |||
Form 4
| +10.04% | 289.3K |
$7.20 | -$1,351,218.80 | 3.17M |
Feb 25 - Feb 26
| |||
Form 4
| +4.59% | 126.41K |
$7.50 | -$620,715.00 | 2.88M |
Jan 29
| |||
Form 4
| +0.30% | 8.17K |
$5.23 | -$27,729.46 | 2.76M |
Dec 31 - Jan 4
| |||
Form 4
| +0.30% | 8.17K |
$4.60 | -$24,389.20 | 2.75M |
Nov 30
| |||
Form 4
| +7.14% | 182.59K |
$3.74 | $232,842.36 | 2.74M |
Nov 9 - Nov 11
| |||
Form 4
| +0.53% | 13.47K |
—
|
—
| 2.56M |
Oct 30
| |||
Form 4
| +0.53% | 13.47K |
—
|
—
| 2.54M |
Sep 30
| |||
Form 4
| +0.32% | 8.17K |
$7.36 | -$39,022.72 | 2.53M |
Aug 31
| |||
Form 4
| +0.33% | 8.17K |
$6.59 | -$34,953.36 | 2.52M |
Jul 31
| |||
Form 4
| +0.33% | 8.17K |
$6.72 | -$35,629.44 | 2.51M |
Jun 30
| |||
Form 4
| +0.33% | 8.17K |
$6.86 | -$36,371.72 | 2.5M |
May 29
| |||
Form 4
| +0.33% | 8.17K |
$8.26 | -$43,794.52 | 2.5M |
Apr 30
| |||
Form 4
| +0.33% | 8.17K |
$13.58 | -$72,001.16 | 2.49M |
Mar 31
| |||
Form 4
| -7.46% | -200.00K |
$15.99 | -$3,198,700.00 | 2.48M |
Scheduled
|
Mar 4
| ||
Form 4
| +0.31% | 8.17K |
$14.67 | -$77,780.34 | 2.68M |
Feb 28 - Mar 2
| |||
Form 4
| +5.48% | 138.91K |
$17.58 | -$1,584,379.92 | 2.67M |
Feb 25
| |||
Form 4
| +8.16% | 191.08K |
$19.04 | -$2,366,424.48 | 2.53M |
Jan 31 - Feb 3
| |||
Form 4
| -10.49% | -274.45K |
$22.65 | -$6,217,371.13 | 2.34M |
Scheduled
|
Nov 19
| ||
Form 4
| -15.38% | -475.55K |
$17.12 | -$8,143,451.79 | 2.62M |
Scheduled
|
Nov 11
| ||
Form 4
| +0.38% | 11.6K |
$2.50 | $29,002.50 | 3.09M |
Oct 28
| |||
Form 4
| +33.17% | 767.37K |
$14.37 | -$7,154,478.12 | 3.08M |
Oct 7
| |||
Form 4/A
| +1.09% | 25K |
$2.50 | $62,497.50 | 2.31M |
Aug 21
| |||
Form 4
| +9.00% | 192K |
$1.56 | $300,010.44 | 2.32M |
Aug 21
| |||
Form 4
| +1.08% | 22.74K |
$19.39 | -$286,138.23 | 2.13M |
Jun 30
| |||
Form 4
| +1.09% | 22.74K |
$20.76 | -$306,355.32 | 2.11M |
Mar 31
| |||
Form 4
| -10.70% | -250.00K |
$21.31 | -$5,327,233.76 | 2.09M |
Scheduled
|
Mar 4
| ||
Form 4
| +10.40% | 220.16K |
$16.94 | -$2,425,418.38 | 2.34M |
Jan 31 - Feb 1
| |||
Form 4
| +1.09% | 22.74K |
$13.24 | -$195,382.68 | 2.12M |
Dec 31
| |||
Form 4
| -8.72% | -200.00K |
$10.21 | -$11,037,621.33 | 2.09M |
Scheduled
|
Nov 12
| ||
Form 4
| +1.00% | 22.74K |
$16.27 | -$240,096.39 | 2.29M |
Sep 30
| |||
Form 4
| +51.01% | 767.37K |
$2.99 | -$1,488,649.24 | 2.27M |
Sep 22
| |||
Form 4
| +1.53% | 22.74K |
$3.09 | -$45,599.13 | 1.5M |
Jun 30
| |||
Form 4
| +1.56% | 22.74K |
$3.01 | -$44,418.57 | 1.48M |
Mar 31
| |||
Form 4
| +26.12% | 302.15K |
$3.83 | -$756,474.79 | 1.46M |
Jan 31 - Feb 1
| |||
Form 4
| +1.92% | 21.77K |
$4.01 | -$63,085.32 | 1.16M |
Dec 31
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +0.89% | 10K |
$3.24 | $32,446.00 | 1.14M |
Nov 30
| |||
Form 4
| +1.97% | 21.77K |
$3.50 | -$55,062.00 | 1.13M |
Sep 30
| |||
Form 4
| +2.01% | 21.77K |
$4.03 | -$63,399.96 | 1.1M |
May 15 - Jun 30
| |||
Form 4
| +2.05% | 21.77K |
$3.20 | -$50,342.40 | 1.08M |
Mar 31
| |||
Form 4
| +42.83% | 317.78K |
$2.97 | -$688,202.46 | 1.06M |
Jan 31 - Feb 1
| |||
Form 4
| +2.39% | 17.31K |
$3.08 | -$62,197.52 | 741.92K |
Dec 31
| |||
Form 4
| +2.45% | 17.31K |
$3.19 | -$64,418.86 | 724.61K |
Sep 30
| |||
Form 4
| +3.33% | 22.78K |
$2.16 | -$31,793.04 | 707.3K |
Jun 30
| |||
Form 4
| +3.44% | 22.78K |
$1.53 | -$22,520.07 | 684.52K |
Mar 31
| |||
Form 4
| +3.93% | 25K |
$1.37 | $34,250.00 | 661.74K |
Feb 1
| |||
Form 4
| +67.83% | 257.34K |
$1.36 | -$234,133.52 | 636.74K |
Jan 31 - Feb 1
| |||
Form 4
| +10.97% | 37.5K |
—
|
—
| 379.4K |
Dec 31
| |||
Form 4
| +12.32% | 37.5K |
—
|
—
| 341.9K |
Sep 30
| |||
Form 4
| +7.03% | 20K |
$2.35 | $47,000.00 | 304.4K |
Aug 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 6
| |||
Form 4
| +147.52% | 169.5K |
—
|
—
| 284.4K |
Jan 31 - Feb 2
| |||
Form 4
| +77.04% | 50K |
$0.83 | $41,600.00 | 114.9K |
Nov 11 - Nov 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 8
| |||
Form 4
| +8.35% | 5K |
$1.90 | $9,500.00 | 64.9K |
Nov 20
| |||
Form 4
| +18.73% | 9.45K |
—
|
—
| 59.9K |
Jul 26
| |||
Form 4
| +27.88% | 11K |
$1.35 | $14,850.00 | 50.45K |
May 29
| |||
Form 4
| +33.96% | 10K |
$1.35 | $13,500.00 | 39.45K |
Jan 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
| +51.41% | 10K |
$1.35 | $13,500.00 | 29.45K |
Sep 24
| |||
Form 4
| +105.82% | 10K |
$1.35 | $13,500.00 | 19.45K |
Sep 11
| |||
Form 4
|
∞
| 9.45K |
$8.36 | -$3,602,112.12 | 9.45K |
Scheduled
|
Jul 26 - Jul 27
| ||
Form 4
|
—
|
0
|
$5.66 | -$1,299,321.93 |
0
|
Scheduled
|
Apr 9
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACUSPHERE INC No price found
Senior VP/CFOJohn F Thero owns 91,504 units of Common Stock.acquired a total of 91,504 shares in ACUSPHERE INC at a cost of $81,996.52.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +325.52% | 70K |
$0.84 | $58,800.00 | 91.5K |
Aug 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
| +1.19% | 252 |
$4.76 | $1,199.52 | 21.5K |
Sep 1
| |||
Form 4
| +4.94% | 1K |
$4.00 | $4,000.00 | 21.25K |
May 13
| |||
Form 4
| +1.26% | 252 |
$4.75 | $1,197.00 | 20.25K |
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
| +100.00% | 10K |
$0.84 | $8,400.00 | 20K |
Jul 6
| |||
Form 4
|
∞
| 10K |
$0.84 | $8,400.00 | 10K |
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VIACELL INC No price found
Sr.VP, Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cyteir Therapeutics, Inc. (CYT) No price found
InvestorJohn F Thero owns 22,828 units of Common Stock. From 2022 to 2024 John F Thero acquired a total of 22,828 shares in Cyteir Therapeutics, Inc. at a cost of $41,679.32.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +128.28% | 12.83K |
$1.69 | $21,679.32 | 22.83K |
Feb 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
|
∞
| 10K |
$2.00 | $20,000.00 | 10K |
May 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||